#46 Covid-19 News in India_ US के Gilead की बनाई Remdesivir Coronavirus का treatment कैसे करेगी? ICMR episode artwork

EPISODE · Mar 17, 2021 · 5 MIN

#46 Covid-19 News in India_ US के Gilead की बनाई Remdesivir Coronavirus का treatment कैसे करेगी? ICMR

from Explainer | Part 1

With the health ministry and ICMR batting for Remdesivir for the treatment of Coronavirus patients in India, Siddhant Mohan of the Lallantop tried to breakdown the medicine over its core. While the medicine has been cleared for intravenous use, its approval is only backed by the research conducted by Gilead pharma, which eventually manufactures Remdesivir.

Episode metadata supplied by the publisher feed · Published Mar 17, 2021

Embed this episode

Ready to play

#46 Covid-19 News in India_ US के Gilead की बनाई Remdesivir Coronavirus का treatment कैसे करेगी? ICMR

0:00 5:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Explainer | Part 1?

This episode is 5 minutes long.

When was this Explainer | Part 1 episode published?

This episode was published on March 17, 2021.

Can I download this Explainer | Part 1 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!